Carregando...
Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis
Hyperphosphatemia is common among patients with CKD stage 5D and is associated with morbidity and mortality. Current guidelines recommend lowering serum phosphate concentrations toward normal. Tenapanor is a minimally absorbed small molecule inhibitor of the sodium/hydrogen exchanger isoform 3 that...
Na minha lista:
| Publicado no: | J Am Soc Nephrol |
|---|---|
| Principais autores: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Nephrology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5461797/ https://ncbi.nlm.nih.gov/pubmed/28159782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2016080855 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|